Efficacy and toxicity of midostaurin with idarubicin and cytarabine induction in <i>FLT3</I>-mutated acute myeloid leukemia

Haematologica. 2023 Dec 1;108(12):3460-3463. doi: 10.3324/haematol.2022.281967.

¹ Department of Pharmacy, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT. julialee@stanfordhealthcare.org.
² Department of Pharmacy, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
³ Department of Pharmacy, Cleveland Clinic Foundation, Cleveland, OH.
⁴ Department of Pharmaceutical Services, University of California San Francisco, San Francisco, CA.
⁵ Department of Hematology and Medical Oncology, Winship Cancer Institute/Emory Healthcare, Atlanta, GA.
⁶ Department of Pharmacy, Oregon Health and Science University Hospital, Portland, OR.
⁷ Division of Public Health, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
⁸ Division of Hematology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.

No abstract available

MeSH terms